Recent breakthroughs in the field of diabetes treatment have introduced a new class of medications known as GLP-1 receptor agonists. These compounds work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://lillitcvc578930.blogsvirals.com/39708124/new-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide